Pregabalin Completed Phase 4 Trials for Diabetic Peripheral Neuropathy (DPN) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00159731Safety of Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy